Audrey Ardern‐Jones

Royal Marsden NHS Foundation Trust

Papers

1

Total Citations

25

H-Index

1

About

Audrey Ardern‐Jones is a pioneering researcher in the field of prostate cancer genetics, whose work has significantly advanced our understanding of hereditary predisposition to the disease. Her research focuses on the identification and characterization of high-risk genes that contribute to prostate cancer development, a critical area for improving early detection and personalized treatment strategies. In her highly cited 2000 paper, "High risk genes predisposing to prostate cancer development—do they exist?" (25 citations), Ardern‐Jones critically examined the evidence for genetic susceptibility, challenging the field to refine its approach to identifying true risk variants. This work has been foundational in shaping subsequent studies on familial prostate cancer and the role of genetic markers in clinical practice. Through her rigorous analysis and clear synthesis of complex genetic data, Ardern‐Jones has helped bridge the gap between basic genomic research and translational applications, making her a respected voice in cancer genetics. Her contributions continue to inspire researchers exploring the intricate interplay between heredity and malignancy.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
High risk genes predisposing to prostate cancer development—do they exist?
25 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Royal Marsden NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago